Home > Inhibitors & Agonists > Others
Cat. No. Product name CAS No.
DCC5219 Trans-ocma

Natural specific inhibitor of γ-secretase, decreasing amyloid-beta levels without influencing cleavage of Notch, showing strong growth inhibitory effects on cancer cell lines and significant anti-complement activity, also acting as a PTP1B inhibitor

DCC5220 trans-resveratrol-3-o-glucuronide

Metabolite of Resveratrol

387372-17-0
DCC5221 trans-resveratrol-4'-o-glucuronide

Metabolite of Resveratrol

387372-20-5
DCC5222 Trantinterol

Novel Highly Selective β2-Adrenoceptor Agonist as an Oral Antiasthmatic Agent

611234-02-7
DCC5223 trapoxin B

Inhibitor of histone deacetylases

133155-90-5
DCC5224 Trc210258

Novel TGR5 agonist, reducing glycemic and dyslipidemic cardiovascular risk in animal models of diabesity

1431553-15-9
DCC5225 Trehalose-6-phosphate

Central sugar signal in plants, regulating sucrose use and allocation, underpinning crop growth and development

4484-88-2
DCC5226 Trenbolone Enanthate

Potent and long-acting derivative of the hormone Trenbolone

1629618-98-9
DCC5227 Triazophos

EC 3.1.1.7 (Acetylcholinesterase) inhibitor, acting as an insecticide, an acaricide, an agrochemical, and a nematicide

24017-47-8
DCC5228 Triciribine Phosphate

AKT Inhibitor, Enhancing Gemcitabine Activity in Pancreatic Cancer Cells

61966-08-3
DCC5229 Tridecyl 2-aminoacetate Hydrochloride

Potent NAE-hydrolyzing acid amidase (NAAA) inhibitor

94856-88-9
DCC5230 Trifluoperazine N-glucuronide

Metabolite of Trifluoperazine; Antidepressant and antipsychotic

165602-90-4
DCC5231 Trifluoroacetyl Lysine

Novel Bromodomain Binding Mimic of Lysine Acetylation

10009-20-8
DCC5232 Trigonellinamide

Metabolite of nicotinamide; Specific and potent inhibitor of NNMT, increasing histone methylation at H3K4 and methylated H3K4 occupancy at gene promoters

3106-60-3
DCC5233 Trimipramine

Antipsychotic and sedative agent as a potent antagonist of H1, 5-HT2A, and alpha1-adrenergic receptors

739-71-9
DCC5234 Tripartin

Specific inhibitor of the histone H3 lysine 9 demethylase KDM4 in HeLa cells.

1428962-73-5
DCC5235 Triplin

Copper ion chelator, causing the triple response phenotype by affecting copper ion transport in ethylene signaling from ATX1 to RAN1

1421584-86-2
DCC5236 Tritiozine

Novel anti-secretory and antiulcer agent for treatment of peptic ulcer disease and hypersecretory disorders

35619-65-9
DCC5237 Trk Inhibitor 7d

First Highly Selective and Broadly Effective Macrocycle-Based Type II TRK Inhibitor that Overcome Clinically Acquired Resistance

DCC5238 Trk-130

Novel opioid ligand for treatment of overactive bladder, acting as a μ-opioid receptor partial agonist

160359-68-2
DCC5239 Trka-in-1

Novel potent and selective inhibitor of Tropomyosin-related kinase A (TrkA)

DCC5240 trmd-in-51

First-in-class highly potent and selective inhibitor of TrmD (bacterial t-RNA-(N1G37) methyltransferase)

1456890-42-8
Page 1109 / Total 1149 FirstPrevNextLastGoto